Chile
8 Vaccines Approved for Use in Chile
RNA
Pfizer/BioNTech
Comirnaty
Approved in 149 countries
100 trials in 31 countries
Approval Source: reuters.com
Non Replicating Viral Vector
Non Replicating Viral Vector
Non Replicating Viral Vector
Janssen (Johnson & Johnson)
Ad26.COV2.S
Approved in 111 countries
23 trials in 23 countries
Approval Source: ispch.cl
Non Replicating Viral Vector
Oxford/AstraZeneca
Vaxzevria
Approved in 149 countries
73 trials in 34 countries
Approval Source: reuters.com
Inactivated
RNA
Non Replicating Viral Vector
Janssen (Johnson & Johnson)
Jcovden
Approved in 113 countries
26 trials in 25 countries
Approval Source: ispch.cl
10 in Clinical Trials in Chile
RNA
Pfizer/BioNTech
Comirnaty
Approved in 149 countries
100 trials in 31 countries
Non Replicating Viral Vector
CanSino
Ad5-nCoV-IH
Approved in 1 country
5 trials in 4 countries
Non Replicating Viral Vector
CanSino
Convidecia
Approved in 10 countries
14 trials in 6 countries
Non Replicating Viral Vector
Janssen (Johnson & Johnson)
Ad26.COV2.S
Approved in 111 countries
23 trials in 23 countries
Non Replicating Viral Vector
Oxford/AstraZeneca
Vaxzevria
Approved in 149 countries
73 trials in 34 countries
Non Replicating Viral Vector
ReiThera
GRAd-COV2
5 trials in 12 countries
Inactivated
Sinovac
CoronaVac
Approved in 56 countries
42 trials in 10 countries
Non Replicating Viral Vector
Janssen (Johnson & Johnson)
Jcovden
Approved in 113 countries
26 trials in 25 countries
Inactivated
Sinovac
CoronaVac Omicron Vaccine
Inactivated
Sinovac